• Boehringer Ingelheim collaborates with Science 37 to accelerate the clinical development of new therapies worldwide
• Science 37’s technology enables patients to remotely participate in clinical studies, which enables increased patient diversity, study efficiency and speed, while decreasing patient burden
INGELHEIM, Germany & PLAYA VISTA, Calif.-Thursday 3 January 2019 [ AETOS Wire ]
(BUSINESS WIRE)-- Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical location. The new collaboration
...
Read more »